精神病超高危人群认知功能和心理状况的比较研究
本文关键词:精神病超高危人群认知功能和心理状况的比较研究 出处:《南方医科大学》2015年硕士论文 论文类型:学位论文
更多相关文章: 精神病超高危 认知功能 精神分裂症 心理状况 内表型
【摘要】:目的:通过精神病超高危组、高危组、首发精神分裂症组、复发精神分裂症组认知功能和心理状况的比较,分析精神病超高危人群的神经认知功能和心理状况与其他人群的差异,寻找潜在的精神病理学相关的内表型指标,为实现亚临床特征(subclinical trait)或前驱期(prodromal)的早期识别、诊断及精神病超高危干预提供依据,改善不良预后,减少功能残疾。方法:分别收集符合入组和排除标准的40例精神分裂症一级亲属精神病超高危受试者、40例精神分裂症一级亲属高危组、40例首发精神分裂症患者、40例复发精神分裂症患者、40例健康对照组作为研究对象。所有研究对象入组后完成以下项目:(1)一般情况及精神病理症状:一般情况采用自制的一般人口学资料调查表;症状学评估采用Montgomery-Asberg抑郁量表(MADRS)、阳性和阴性症状量表(PANSS)。(2)社会心理评估:采用儿童期经历问卷、家庭亲密度和适应性量表、生活事件量表、社会支持量表、卢森堡自尊量表、应付方式量表等心理评估工具。(3)神经认知功能评估:采用连线测验(the Trail Making Test Part A, TMTA)、符号编码(Symbol coding Test)、霍普金斯词语学习测验修订版(Hopkins Verbal Learning Test-Revised, HVLT-R)、简易视觉记忆测验修订版(Brief Visuospatial Memory Test-Revised, BVMT-R)、Stroop色词测验(Stroop Color WordTest, Stroop C-W)、持续操作测验(Continuous Performance Test, CPT)等认知功能测验。主要比较精神病超高危组在认知功能及心理状况方面与其他各组的差异。结果:1.症状学比较结果:(1)抑郁症状比较结果:精神病超高危组抑郁情况好于首发精神分裂症组和复发精神分裂症组,差于高危组和健康对照组,具有统计学意义(p0.05);(2)PANSS量表比较结果:精神病超高危组情况要好于首发精神分裂症组和复发精神分裂症组,但比高危组和健康对照组差,具有统计学意义(p<0.05)。2.社会心理学比较结果:(1)儿童期经历问卷结果表明,精神病超高危组在儿童期经历得分方面显著低于首发精神分裂症组、复发精神分裂症组、健康对照组,有统计学意义p0.05),与高危组之间不存在显著差异(p<0.05);(2)家庭亲密度和适应性量表结果表明,在亲密度得分方面,精神病超高危组、高危组、首发精神分裂症组、复发精神分裂症组四组之间不存在显著差异(p<0.05),但是健康对照组显著高于其他各组。在适应性得分方面,精神病超高危组、健康对照组得分显著高于高危组、首发精神分裂症组和复发精神分裂症组, 具有统计学意义(p0.05);(3)生活事件量表结果表明,生活事件量表各维度得分方面不存在显著的差异(p0.05);(4)社会支持量表结果表明,精神病超高危组、高危组得分显著高于首发精神分裂症组和复发精神分裂症组得分,健康对照组得分最高,具有统计学意义(p<0.05);(5)卢森堡自尊量表结果表明,精神病超高危组得分与健康对照组得分没有显著差异(p<0.05),但是显著高于高危组、首发精神分裂症组和复发精神分裂症组(p0.05);(6)应付方式量表结果表明,在合理化维度五组间无统计学意义(p0.05),在解决问题维度,精神病超高危组、高危组和健康对照组得分显著高于复发精神分裂症组得分,复发精神分裂症组得分又显著高于首发精神分裂症组得分;在自责方面,精神病超高危组、高危组和健康对照组得分显著低于首发精神分裂症组和复发精神分裂症组得分;在求助方面,精神病超高危组、高危组和健康对照组得分显著低于首发精神分裂症组和复发精神分裂症组得分;在幻想方面,健康对照组得分显著低于其他几组的得分;在退避方面,健康对照组得分显著低于高危组、首发精神分裂症组和复发精神分裂症组得分。3.神经认知功能比较结果:(1)在连线测验(TMTA)方面方面,精神病超高危组得分显著短于首发精神分裂症组和复发精神分裂症组,但比高危组和健康对照组用时长,具有统计学意义(p0.05);(2)在符号编码方面,精神病超高危组得分高于首发精神分裂症组和复发精神分裂症组,但低于高危组和健康对照组,具有统计学意义(P0.05);(3)在霍普金斯语言学习(HYLT-R)方面,高危组和健康对照组得分较高,精神病超高危组、首发精神分裂症组和复发精神分裂症组得分较低,有统计学意义(p<0.05);(4)在简易视觉记忆测验(BVMT-R)方面,健康对照组得分最高,首发精神分裂症组和复发精神分裂症组得分最低,精神病超高危组和高危组介于前两者之间,具有统计学意义(p<0.05);(5)在Stroop色词测验方面,精神病超高危组成绩好于首发精神分裂症组和复发精神分裂症组,但是又比高危组和健康对照组差,具有统计学意义(p<0.05);(6)在持续操作测验(CPT)方面,精神病超高危组成绩好于首发精神分裂症组和复发精神分裂症组,但比高危组和健康对照组差,具有统计学意义(p<0.05)。结论:1.精神病超高危人群出现精神病理症状,尚未达到精神病诊断标准。2.精神病超高危人群的家庭亲密度和个人内心领悟能力下降。3.精神病超高危人群出现广泛的认知功能受损,涉及信息处理速度、记忆力、注意力等方面。其中信息处理速度异常可能是精神分裂症内表型的预警因素。4.精神分裂症阳性家族史的高危人群的认知功能下降,提示可能存在遗传素质因素影响。
[Abstract]:Objective: through mental illness at ultra high risk group, high risk group, first-episode schizophrenia group, compare the recurrence function and psychological status of patients with mental cognitive division, difference analysis of people at ultra high risk of psychosis neurocognitive function and psychological status with other people, to find some endophenotype related psychopathology potential, to achieve sub the clinical features (subclinical trait) or prodromal period (prodromal) early identification, provide the basis for the diagnosis and intervention of mental illness at ultra high risk, improve the prognosis and reduce disability. Methods: 40 cases treated with row and spirit in addition to the standard of schizophrenia in the first-degree relatives of psychiatric ultra high-risk subjects, 40 cases first degree relatives of schizophrenia in high-risk group, 40 cases of patients with first-episode schizophrenia, 40 cases of recurrence in patients with schizophrenia and 40 healthy control group as the research object. All the research objects into the group after the completion of the project : (1) general and psychiatric symptoms: general situation using the self-made demographic data questionnaire; symptom assessment by Montgomery-Asberg Depression Scale (MADRS), positive and negative symptom scale (PANSS). (2) social psychological assessment: the childhood experience questionnaire, family cohesion and adaptability scale and the life events scale, social support scale, Luxemburg self esteem scale, coping style questionnaire and psychological assessment tools. (3) neurocognitive assessment: the connection test (the Trail Making Test Part A, TMTA), the symbol encoding (Symbol coding Test), the Hopki Verbal Learning Test revised (Hopkins Verbal Learning Test-Revised, HVLT-R), simple visual memory test revised (Brief Visuospatial Memory Test-Revised, BVMT-R), Stroop color word test (Stroop Color WordTest, Stroop C-W, continuous performance test (Continuou) S Performance Test, CPT) and other cognitive function test. The main difference between mental illness at ultra high risk group in the cognitive function and psychological status with other groups. Results: 1. symptom comparison: (1) comparison results: depressive symptoms at ultra high risk of psychosis group depression was better than the first onset schizophrenia group and recurrence the schizophrenia group, difference in high risk group and healthy control group, with statistical significance (P0.05); (2) the PANSS scale comparison results: psychotic super high risk group than in schizophrenia group and recurrent schizophrenia group, but high risk group and healthy control group difference was statistically significant (P < 0.05).2. (1): the social psychology of childhood experience questionnaire. The results show that the ultra high risk group mental illness in childhood experience score was significantly lower than the schizophrenia group, recurrent schizophrenia group and healthy control group, the Statistical significance of P0.05), and there is no significant difference between the high risk group (P < 0.05); (2) the family adaptability and cohesion scale results in cohesion scores, psychosis super high risk group, high risk group, schizophrenia group, recurrent schizophrenia group there is no significant difference between the four between the groups (P < 0.05), but the control group was significantly higher than the other groups. The adaptability scores, mental illness at ultra high risk group, healthy control group scored significantly higher than the high-risk group, schizophrenia group and recurrent schizophrenia group, with statistical significance (P0.05); (3) the results of life event scale show that life events scores have no significant difference (P0.05); (4) social support scale. The results showed that mental illness at ultra high risk group, high risk group scored significantly higher than the schizophrenia group and recurrent schizophrenia group scores of health Compared with the highest score, with statistical significance (P < 0.05); (5) the Luxemburg self esteem scale. The results show that the ultra high risk group and the scores of psychiatric health control group scores had no significant difference (P < 0.05), but significantly higher than the high-risk group, schizophrenia group and recurrent schizophrenia group (P0.05); (6) coping style questionnaire. The results show that the rationalization of the five groups had no statistical significance (P0.05), to solve the problem of dimension, mental illness at ultra high risk group, high risk group and healthy control group was significantly higher than that of the recurrence of schizophrenia group score, recurrent schizophrenia group score was significantly higher than that of first division and spirit in the score division; in the era, psychosis super high risk group, high risk group and healthy control group were significantly lower than the schizophrenia group and recurrent schizophrenia group score; in turn, psychosis super high risk group, high risk group and healthy controls Group had significantly lower scores of first-episode schizophrenia group and recurrent schizophrenia group score; in the fantasy, the healthy control group were significantly lower than that of other groups of scores; in the backoff, the healthy control group were significantly lower than the high-risk group, schizophrenia group and recurrent schizophrenia group.3. score comparison results of neurocognitive function: (1) in the connection test (TMTA) aspects of mental illness, ultra high-risk group scored significantly shorter in the schizophrenia group and recurrent schizophrenia group, but higher than the high-risk group and healthy control group in long time, with statistical significance (P0.05); (2) in the symbol encoding, mental disease ultra high risk group were higher than that of schizophrenia group and recurrent schizophrenia group, but lower than the high risk group and healthy control group, with statistical significance (P0.05); (3) study in Hopki language (HYLT-R), high risk group and healthy The control group scored higher, psychosis super high risk group, schizophrenia group and recurrent schizophrenia group lower scores was statistically significant (P < 0.05); (4) in a simple visual memory test (BVMT-R), healthy control group had the highest scores, schizophrenia group and recurrent schizophrenia the lowest score between group, mental illness at ultra high risk group and high risk group between the first two, with statistical significance (P < 0.05); (5) in the Stroop color word test, psychosis super high risk group is better than the schizophrenia group and recurrent schizophrenia group, but also than the high-risk group and healthy controls group difference was statistically significant (P < 0.05); (6) in the continuous performance test (CPT), psychosis super high risk group is better than the schizophrenia group and recurrent schizophrenia group, but higher than the high-risk group and healthy control group difference was statistically significant (P < 0.05). Conclusion: 1. people at ultra high risk of psychosis mental symptoms, psychiatric diagnosis has not yet reached the standard of.2. people at ultra high risk of psychosis family cohesion and inner personal comprehension ability decreased.3. people at ultra high risk of psychosis appear extensive cognitive impairments, information processing speed, memory, attention and cognitive function among high-risk groups. Early warning factors of information processing speed may be abnormal in schizophrenia phenotype.4. schizophrenia positive family history of the decline, indicating the effect of genetic quality factors.
【学位授予单位】:南方医科大学
【学位级别】:硕士
【学位授予年份】:2015
【分类号】:R749.3
【相似文献】
相关期刊论文 前10条
1 陈方煜,蔡昌群,万承龙,武慎彬,阳中明,汪开山;利培酮治疗20例首发精神分裂症的疗效分析[J];四川精神卫生;2000年03期
2 陈方煜,蔡昌群,万承龙,武慎彬,阳中明,汪开山;利培酮治疗首发精神分裂症[J];皖南医学院学报;2000年03期
3 李秀华;在校生首发精神分裂症108例临床分析[J];现代康复;2000年13期
4 陈海支,尹刚,李新胜,刘晓华,徐静;不同预后的首发精神分裂症患者免疫球蛋白及补体成分的研究[J];中华精神科杂志;2001年02期
5 李献云,费立鹏,张培琰,吉中孚;首发精神分裂症病人的抑郁症状[J];中国神经精神疾病杂志;2001年02期
6 李菲菲,费立鹏,李兰英,孟梅,阎德亮;首发精神分裂症家庭情感表达特点[J];中国心理卫生杂志;2001年05期
7 王娴贤,陈平周,洪晓虹,陈曲亮;利培酮对首发精神分裂症疗效观察[J];神经疾病与精神卫生;2001年04期
8 孙传贤,孙文仪;首发精神分裂症复发的原因分析[J];临床精神医学杂志;2001年06期
9 倪峻华,欧阳筠淋;利培酮治疗首发精神分裂症临床观察[J];山东精神医学;2001年02期
10 左津淮,寻知元,王茂华,曹毅;利培酮治疗首发精神分裂症患者的疗效分析[J];四川精神卫生;2001年03期
相关会议论文 前10条
1 秦天星;郭细先;曾德志;华曙光;;首发精神分裂症患者家庭环境对其复发的影响[A];2009年浙江省医学会精神病学学术年会暨浙江省医师协会精神科医师分会第二届年会论文汇编[C];2009年
2 汤庆平;朱培俊;赖根祥;张静;;阿立哌唑和利培酮治疗首发精神分裂症的对照[A];2009年浙江省医学会精神病学学术年会暨浙江省医师协会精神科医师分会第二届年会论文汇编[C];2009年
3 施剑飞;沈鉴清;;阿立派唑与利培酮治疗门诊首发精神分裂症的临床研究[A];2006年浙江省精神病学学术会议论文汇编[C];2006年
4 陈梅芳;;阿立派唑与利培酮治疗首发精神分裂症的对照研究[A];2006年浙江省精神病学学术会议论文汇编[C];2006年
5 张君青;罗忠;周斌斌;;首发精神分裂症患者亲属的心理健康状况分析[A];2006年浙江省精神病学学术会议论文汇编[C];2006年
6 陈铭;张咏梅;;阿立哌唑治疗首发精神分裂症临床观察[A];中华医学会精神病学分会第七届学术年会论文摘要集[C];2006年
7 黄继伟;张生;彭海艮;陆先臻;;阿立哌唑与利培酮治疗首发精神分裂症对照研究[A];中华医学会精神病学分会第七届学术年会论文摘要集[C];2006年
8 鲁从林;吴华玲;周忠莲;张峰;金俊;杨勇;;阿立哌唑治疗首发精神分裂症临床观察[A];中华医学会精神病学分会第七届学术年会论文摘要集[C];2006年
9 郭琴;潘苗;张凌芳;;综合干预对首发精神分裂症患者预后的影响[A];2007河南省精神卫生学术研讨会资料汇编[C];2007年
10 庞礼娟;宋学勤;吕路线;赵靖平;李幼辉;李雪;高金松;;在校学生首发精神分裂症患者临床特征及疗效分析[A];中华医学会精神病学分会第九次全国学术会议论文集[C];2011年
相关重要报纸文章 前2条
1 薛原;三成非首发精神分裂症患者存在服药依从性问题[N];健康报;2007年
2 ;氯氮平和利培酮对首发精神分裂症患者糖代谢影响的研究[N];中国医药报;2003年
相关博士学位论文 前3条
1 陶好娟;首发精神分裂症患者脑灰质和脑网络的磁共振成像研究[D];中南大学;2012年
2 刘登堂;首发精神分裂症患者的认知功能及功能磁共振成像研究[D];复旦大学;2003年
3 张会然;首发精神分裂症患者不同症状维度多模态磁共振成像研究[D];中南大学;2013年
相关硕士学位论文 前10条
1 李国华;胶质纤维酸性蛋白及基因多态性与首发精神分裂症的相关性研究[D];昆明医科大学;2013年
2 黑钢瑞;首发精神分裂症患者肠道菌群与炎性因子的相互作用研究[D];郑州大学;2015年
3 祁继鹏;首发精神分裂症及超高危人群的认知功能对照研究[D];新乡医学院;2015年
4 陈领;共情能力对首发精神分裂症患者自知力的影响[D];安徽医科大学;2015年
5 石贺敏;首发精神分裂症患者随访1年复发规律及相关因素分析[D];华北理工大学;2015年
6 王中磊;精神病超高危人群认知功能和心理状况的比较研究[D];南方医科大学;2015年
7 方今女;首发精神分裂症的五年随访结构[D];延边大学;2005年
8 李惠芳;家庭社会经济情况教养方式家庭环境与首发精神分裂症的相关研究[D];兰州大学;2007年
9 万静;首发精神分裂症患者血清细胞因子浓度与临床症状相关性研究[D];昆明医学院;2010年
10 胡茂荣;首发精神分裂症患者及其健康同胞认知功能的研究[D];中南大学;2009年
,本文编号:1420450
本文链接:https://www.wllwen.com/yixuelunwen/jsb/1420450.html